CPC C07D 215/233 (2013.01) [C07B 2200/13 (2013.01)] | 16 Claims |
1. A crystalline form of cabozantinib acesulfamate, characterized by a PXRD diffractogram comprising peaks, expressed in degrees 2θ (±0.2°), at 9.5°, 11.2°, and 19.7°.
|